GGrantIndex
← Search

Administrative Supplements for the P30 Cancer Center Support Grants to Enhance Sexual Orientation and Gender Identity (SOGI) Data Collection

$150,000P30FY2022CANIH

University Of Southern California, Los Angeles CA

Investigators

Linked publications, trials & patents

Trial NCT07456436Trial NCT07339254Trial NCT07332312Trial NCT07312162Trial NCT07306338Trial NCT07279571Trial NCT07276048Trial NCT07259304Trial NCT07229443Trial NCT07186699Trial NCT07162194Trial NCT07082257Trial NCT07076147Trial NCT06500169Trial NCT06422455Trial NCT06420219Trial NCT06374251Trial NCT06338657Trial NCT06336928Trial NCT06336902Trial NCT06297265Trial NCT06191575Trial NCT06171607Trial NCT06132087Trial NCT06128525Trial NCT06067295Trial NCT06063928Trial NCT06063486Trial NCT06060873Trial NCT05989828Trial NCT05791448Trial NCT05786664Trial NCT05516485Trial NCT05514990Trial NCT05462561Trial NCT05340309Trial NCT04981834Trial NCT04941430Trial NCT04927559Trial NCT04832763Trial NCT04830735Trial NCT04752267Trial NCT04387084Trial NCT04387071Trial NCT04373044Trial NCT04318028Trial NCT04315701Trial NCT04162678Trial NCT03971266Trial NCT03921047Trial NCT03858205Trial NCT03789773Trial NCT03739801Trial NCT03698162Trial NCT03657641Trial NCT03594448Trial NCT03576963Trial NCT03568292Trial NCT03568266Trial NCT03563651Trial NCT03563352Trial NCT03552796Trial NCT03537690Trial NCT03519984Trial NCT03514927Trial NCT03492801Trial NCT03485794Trial NCT03412370Trial NCT03408561Trial NCT03353896Trial NCT03348137Trial NCT03344211Trial NCT03330821Trial NCT03300609Trial NCT03300401Trial NCT03284346Trial NCT03267680Trial NCT03257761Trial NCT03238664Trial NCT03234556Trial NCT03207854Trial NCT03176979Trial NCT03146871Trial NCT03137706Trial NCT03120390Trial NCT03111823Trial NCT03098277Trial NCT03092856Trial NCT03091842Trial NCT03091816Trial NCT03091803Trial NCT03057639Trial NCT03049618Trial NCT03042897Trial NCT02978846Trial NCT02970617Trial NCT02970045Trial NCT02968680Trial NCT02967380Trial NCT02960308

Abstract

Abstract Compared to heterosexual and cisgender populations, SGM populations face disparities related to cancer occurrence and outcomes, including barriers in cancer prevention, treatment, and survivorship care, and significant disparities in cancer risk factors. Despite these disparities, SGM cancer research is hampered by a lack of sexual orientation and gender identity (SOGI) data collection in clinical settings and in population-based surveillance data (especially cancer registries), and as a result, incidence, and mortality trends for SGM populations are difficult to document. The National Academies of Science, Engineering, and Medicine recently recommended that the NIH adopt standardized and parsimonious practices for collecting data on sex, gender, and sexual orientation to address these challenges. The USC/Norris Comprehensive Cancer Center (NCCC) adopted standardized data collection for SOGI during 2018 across its data systems (at the central hospital and outlying clinics), but those data are collected in optional forms in a “Social/Sexual History” tab, and to date there has been no effort to determine how complete or representative those data are. NCCC evaluates and treats cancer patients from Los Angeles County’s safety net hospital (LAC/USC), which also adopted voluntary collection of SOGI data fields in 2018. Provider training in the existence and use of SOGI data items has been provided on an ad hoc basis. To evaluate the potential utility of these data in advancing SGM research across the cancer continuum, we propose the following Specific Aims: Aim 1. Study the implementation of standardized SOGI data collection at NCCC Aim 2. Assess patient-, provider-, and clinic/organizational-level barriers and facilitators toward implementation of standardized SOGI data collection by surveying patients who did, and did not, answer SOGI questions. Aim 3. Link LAC/USC and USC/Norris records to the Los Angeles Cancer Surveillance Program (LA’s SEER Registry) and describe the intersection of patient-reported SOGI data items and Registry-based gender (Male/Female/Other/Unknown) values, as well as the burden of common cancers among gender minority cancer patients, comparing incidence, stage of disease, and survival of those patients whose SOGI was misclassified in the Registry. Aim 4. Pilot and evaluate provider training in SOGI data collection. Our ultimate goal will be to document implementation processes and identify and pilot viable solutions to support full integration and use of standardized SOGI data collection in the clinical setting to support surveillance and research. By linking data with the LA SEER registry, we will be able to document the need for including SOGI data collection in population-based cancer registries and begin to track outcomes for SGM individuals on a population basis.

View original record on NIH RePORTER →